Dr. Ryan Salmon, OTD, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 79 Chilkat Ave, Haines, AK 99827 Phone: 907-314-0808 |
Mrs. Brianna Gibbs Cooper, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 69 Beach Road, Haines, AK 99827 Phone: 907-766-2101 |
Southeast Ot Llc Occupational Therapist Medicare: Medicare Enrolled Practice Location: 206 Piedad Road, Haines, AK 99827 Phone: 907-314-0081 |
Matthew William Barkofske, OTD Occupational Therapist Medicare: Medicare Enrolled Practice Location: 69 Beach Road, Haines, AK 99827 Phone: 907-766-2101 |
Four Ravens Occupational Therapy Llc Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 69 Beach Road, Haines, AK 99827 Phone: 907-314-0808 Fax: 907-766-2104 |
Robert Bowers, MS, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 69 Beach Road, Haines, AK 99827 Phone: 907-766-2101 Fax: 907-766-2104 |
Four Ravens Occupational Therapy Llc Occupational Therapist Medicare: Medicare Enrolled Practice Location: 69 Beach Road, Haines, AK 99827 Phone: 907-766-2101 Fax: 907-766-2104 |
Lioba Sophie Menger, MS, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 69 Beach Road, Haines, AK 99827 Phone: 907-766-2101 Fax: 907-766-2104 |
Margaret Michaelene Heyman-hotch, MOT, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 69 Beach Road, Haines, AK 99827 Phone: 907-766-2101 Fax: 907-766-2104 |
News Archive
The first trial to study patients with acute coronary syndrome who do not undergo coronary stenting or bypass surgery found no significant difference between two anti-clotting drugs - prasugrel and clopidogrel - in preventing the first occurrence of death, heart attack or stroke, according to Duke University Medical Center cardiologists.
A devastating genetic disease called CDKL5 deficiency disorder (CDD), which strikes in early childhood, may be significantly treatable even in adulthood, a new study from the Perelman School of Medicine at the University of Pennsylvania suggests.
Researchers have completed a successful clinical trial, managing to detect and image radioactive tracers used in PET and in SPECT scans at the same time, with the hope of enabling doctors to scan patients for abnormalities in shorter times while reducing the amount of radiation patients would be exposed to.
Intravenous bevacizumab should be considered as a first-line therapy for the treatment of refractory bleeding in patients with severe hereditary hemorrhagic telangiectasia, reports Mayo Clinic Proceedings
› Verified 4 days ago